Biogen develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company products address diseases such as multiple sclerosis, non-hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.
£10,916M
7
£1,559M
MERGERLINKS LIMITED • 15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM • CONTACT@MERGERLINKS.COM
© COPYRIGHT 2023 MERGERLINKS.COM. ALL RIGHTS RESERVED.
Nightstar Therapeutics
Biogen
£663m
30 dealmakers
Nightstar Therapeutics
Biogen
£663m
30 dealmakers
Nightstar Therapeutics
Biogen
£663m
30 dealmakers
Nightstar Therapeutics
Biogen
£663m
30 dealmakers
Nightstar Therapeutics
Biogen
£663m
30 dealmakers